Synapse - Works

Results (4073)

The presence and extent of extracapsular extension (ECE) and the need for axillary lymph node dissection (ALND) in patients who meet ACOSOG Z11 eligibility criteria

Meeting Abstract

Dengel, L.; Cody, H. S.; King, T. A.; Van Zee, K. J.; Patil, S.; Corben, A.; El-Tamer, M.; Stempel, M.; Sclafani, L. M.; Heerdt, A. S.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Patterns of care study of adult medulloblastoma

Meeting Abstract

Cosman, R.; Brown, C.; DeBraganca, K.; Khasraw, M.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

RILOMET-1: An international phase III multicenter, randomized, double-blind, placebo-controlled trial of rilotumumab plus epirubicin, cisplatin, and capecitabine (ECX) as first-line therapy in patients with advanced MET-positive gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

Meeting Abstract

Cunningham, D.; Al-Batran, S. E.; Davidenko, I.; Ilson, D. H.; Murad, A. M.; Tebbutt, N. C.; Jiang, Y.; Lou, E.; Dubey, S.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase I study of the safety and pharmacokinetics of DSTP3086S, an anti-STEAP1 antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (CRPC)

Meeting Abstract

Danila, D. C.; Szmulewitz, R. Z.; Higano, C. S.; Gilbert, H.; Kahn, R. S.; Wood, K.; Agarwal, P.; Lin, K.; Kabbarah, O.; Fine, B. M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Alliance A091103: Multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib for the treatment of angiosarcoma

Meeting Abstract

D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Adkins, D.; Perdekamp, M. T. G.; Condy, M. M.; Hartley, E.; Antonescu, C. R.; Schwartz, G. K.; Tap, W. D.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)

Meeting Abstract

Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Poor prognostic features in angiosarcoma: A single institution retrospective study of 324 patients

Meeting Abstract

D'Angelo, S. P.; Moraco, N. H.; Qin, L. X.; Kuk, D.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Antonescu, C. R.; Singer, S.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Tumor pharmacokinetics (PK) and pharmacodynamics (PD) of SAR245409 (XL765) and SAR245408 (XL147) administered as single agents to patients with recurrent glioblastoma (GBM): An Ivy Foundation early-phase clinical trials consortium study

Meeting Abstract

Cloughesy, T. F.; Mischel, P. S.; Omuro, A. M. P.; Prados, M.; Wen, P. Y.; Wu, B.; Rockich, K.; Xu, Y.; Lager, J. J.; Mellinghoff, I. K.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX for first-line therapy of patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led phase II randomized study

Meeting Abstract

Cohen, D. J.; Christos, P. J.; Kindler, H. L.; Catenacci, D. V. T.; Bekaii-Saab, T. B.; Tahiri, S.; Janjigian, Y. Y.; Gibson, M. K.; Chan, E.; Rajdev, L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Long-term disease control of ≥2 years achieved with cabozantinib in subjects with metastatic medullary thyroid carcinoma on a phase I study

Meeting Abstract

Cohen, E. E. W.; Hong, D. S.; Pfister, D. G.; Salgia, R.; Burtness, B.; Cohen, R. B.; Ball, D. W.; Mehra, R.; Mangeshkar, M.; Yaron, Y.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save